McKesson Europe AG (CAKFY) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
McKesson Europe AG (CAKFY) opera en el sector Healthcare, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 35/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026McKesson Europe AG (CAKFY) Resumen de Asistencia Médica y Tuberías
McKesson Europe AG, a subsidiary of McKesson Corporation, is a major player in the European pharmaceutical distribution and retail pharmacy sectors. Operating through a network of wholesale branches, distribution centers, and retail pharmacies, the company provides pharmaceutical products, healthcare services, and pharmacy management solutions across multiple European countries.
Tesis de Inversión
McKesson Europe AG presents a complex investment case. The company's extensive distribution network and retail pharmacy presence across Europe provide a stable revenue base. However, the company's negative profit margin of -0.5% and a high P/E ratio of -73.27 raise concerns about profitability. Growth catalysts include expanding e-commerce and home care services. Key risks include regulatory changes in the pharmaceutical industry and competition from other distributors. Investors should closely monitor the company's efforts to improve profitability and adapt to evolving market dynamics.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Operates approximately 2,000 owned pharmacies and supports 8,000 members in its brand partnership program, indicating a strong retail presence.
- Serves approximately 40,000 pharmacies and hospitals through its 90 wholesale branches, showcasing a wide distribution network.
- Profit Margin is -0.5%, indicating potential challenges in achieving profitability.
- P/E ratio is -73.27, reflecting the company's current earnings situation.
- Beta of 0.13 suggests low volatility compared to the overall market.
Competidores y Pares
Fortalezas
- Extensive distribution network across Europe.
- Strong retail pharmacy presence with the Lloyds Pharmacy brand.
- Established relationships with pharmacies and hospitals.
- Part of the global McKesson Corporation.
Debilidades
- Negative profit margin.
- High P/E ratio.
- Exposure to regulatory changes in the pharmaceutical industry.
- Dependence on the European market.
Catalizadores
- Ongoing: Expansion of e-commerce and home care services to drive revenue growth.
- Ongoing: Strategic partnerships and acquisitions to expand market presence.
- Ongoing: Development of value-added services for pharmacists to strengthen customer relationships.
- Ongoing: Geographic expansion within Europe to increase market share.
- Ongoing: Focus on specialty pharmaceuticals to capitalize on the growing market.
Riesgos
- Ongoing: Increasing competition from other pharmaceutical distributors and retail pharmacy chains.
- Potential: Pricing pressures from governments and healthcare providers.
- Potential: Economic downturn in Europe affecting consumer spending on healthcare products.
- Potential: Disruptions in the supply chain impacting the availability of pharmaceutical products.
- Potential: Regulatory changes in the pharmaceutical industry impacting pricing and distribution.
Oportunidades de crecimiento
- Expansion of E-commerce and Home Care Services: McKesson Europe AG can capitalize on the growing demand for online pharmacy services and home healthcare. The e-commerce market in Europe is projected to reach $200 billion by 2028, offering a significant growth opportunity. By expanding its online platform and home care offerings, McKesson Europe AG can reach a wider customer base and increase revenue streams. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with healthcare providers and acquiring smaller pharmacy chains can expand McKesson Europe AG's market presence and service offerings. The company can leverage partnerships to offer integrated healthcare solutions and enhance customer loyalty. Timeline: Ongoing.
- Development of Value-Added Services for Pharmacists: McKesson Europe AG can further develop and expand its services for pharmacists, such as pharmacy cooperation programs and management tools. By providing value-added services, the company can strengthen its relationships with pharmacists and increase its market share. Timeline: Ongoing.
- Geographic Expansion within Europe: Expanding into new geographic markets within Europe can drive growth for McKesson Europe AG. By entering underserved markets or acquiring existing pharmacy chains, the company can increase its revenue and market share. Timeline: Ongoing.
- Focus on Specialty Pharmaceuticals: The market for specialty pharmaceuticals is growing rapidly, driven by the development of new and innovative therapies. McKesson Europe AG can focus on distributing specialty pharmaceuticals and providing related services to capitalize on this trend. Timeline: Ongoing.
Oportunidades
- Expansion of e-commerce and home care services.
- Strategic partnerships and acquisitions.
- Development of value-added services for pharmacists.
- Growth in the specialty pharmaceuticals market.
Amenazas
- Increasing competition from other pharmaceutical distributors and retail pharmacy chains.
- Pricing pressures from governments and healthcare providers.
- Economic downturn in Europe.
- Disruptions in the supply chain.
Ventajas competitivas
- Extensive Distribution Network: Operates a large network of wholesale branches and distribution centers across Europe.
- Strong Retail Pharmacy Presence: Operates a significant number of retail pharmacies under the Lloyds Pharmacy brand.
- Established Brand Reputation: Has a long history and established brand reputation in the European pharmaceutical market.
- Part of McKesson Corporation: Benefits from the resources and expertise of its parent company, McKesson Corporation.
Acerca de CAKFY
McKesson Europe AG, formerly known as Celesio AG, traces its roots back to 1835 and is headquartered in Stuttgart, Germany. The company changed its name in September 2017 after becoming a subsidiary of McKesson Corporation. McKesson Europe AG operates in the pharmaceutical and healthcare sectors, providing logistics and other services. It has two primary divisions: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division is involved in the wholesale of pharmaceutical and healthcare products, serving approximately 40,000 pharmacies and hospitals through 90 wholesale branches and operating 70 distribution centers across Europe. The Retail Pharmacy division operates around 2,000 owned pharmacies and has approximately 8,000 members in its brand partnership program. This division provides outpatient drug, e-commerce, and home care services, primarily under the Lloyds Pharmacy brand in countries like Belgium, Ireland, Italy, and the United Kingdom. The division offers traditional prescription drugs, over-the-counter products, and medical services. McKesson Europe AG also provides services for pharmacists, including the organization and management of pharmacy cooperation programs in Great Britain, France, Portugal, and Belgium.
Qué hacen
- Wholesale distribution of pharmaceutical products to pharmacies and hospitals.
- Operation of retail pharmacies under the Lloyds Pharmacy brand.
- Provision of outpatient drug services.
- E-commerce services for pharmaceutical products.
- Home care services.
- Management of pharmacy cooperation programs.
- Distribution of traditional prescription drugs and over-the-counter products.
- Provision of medical services.
Modelo de Negocio
- Generates revenue through the wholesale distribution of pharmaceutical products.
- Earns revenue from the operation of retail pharmacies and the sale of prescription and over-the-counter drugs.
- Provides e-commerce services, generating revenue through online sales.
- Offers home care services, generating revenue through service fees.
Contexto de la Industria
McKesson Europe AG operates in the competitive pharmaceutical distribution and retail pharmacy industry. The industry is characterized by increasing demand for healthcare services, driven by an aging population and rising prevalence of chronic diseases. Key trends include the growth of e-commerce and home care services, as well as increasing regulatory scrutiny. McKesson Europe AG competes with other major distributors and retail pharmacy chains, such as ABCZF (All American Healthcare Corp), ANHGY (Anthem Inc), ARHCF (Arches Health Care, Inc.), ASPHF (Aspen Healthcare Inc), and DCHPF (Direct Communication Healthcare).
Clientes Clave
- Pharmacies: Supplies pharmaceutical products to approximately 40,000 pharmacies.
- Hospitals: Distributes pharmaceutical products to hospitals.
- Individual Patients: Serves patients through its retail pharmacies and e-commerce platform.
- Pharmacists: Provides services and support to pharmacists through its pharmacy cooperation programs.
Finanzas
Gráfico e información
Precio de la acción de McKesson Europe AG (CAKFY): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para CAKFY.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CAKFY.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CAKFY.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CAKFY en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Tilo Köster
Managing Director
Information on Tilo Köster's background is limited. He currently serves as Managing Director of McKesson Europe AG, overseeing the company's operations across its Pharmaceutical Distribution and Retail Pharmacy divisions. His responsibilities include managing a large workforce of over 26,000 employees and driving the company's strategic initiatives in the European market.
Historial: Due to limited information, Tilo Köster's specific achievements and strategic decisions at McKesson Europe AG are not readily available. His leadership is focused on navigating the complexities of the European pharmaceutical market and driving growth through strategic partnerships and operational efficiencies.
Información del mercado OTC de CAKFY
The OTC Other tier represents the lowest tier of the OTC market, indicating that McKesson Europe AG (CAKFY) may not meet the minimum financial or regulatory requirements for higher tiers like OTCQX or OTCQB. Companies on this tier may have limited reporting requirements, leading to less transparency for investors compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies with distressed financials, shell corporations, or those that choose not to comply with stricter reporting standards.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited Transparency: OTC Other companies often have minimal reporting requirements, making it difficult to assess their financial health.
- Low Liquidity: Low trading volume can lead to wide bid-ask spreads and difficulty in executing trades.
- Price Volatility: The lack of liquidity can result in significant price swings.
- Potential for Fraud: The lower regulatory oversight increases the risk of fraudulent activities.
- Delisting Risk: The company may not meet the requirements for listing on higher tiers or major exchanges.
- Verify the company's registration and regulatory filings.
- Review the company's financial statements, if available.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC Other companies.
- Consult with a financial advisor.
- Check for any legal or regulatory issues.
- Subsidiary of McKesson Corporation: Being a subsidiary of a well-established company like McKesson Corporation provides some level of assurance.
- Operational Business: The company has a clear business model and operates in the pharmaceutical distribution and retail pharmacy sectors.
- Employee Count: The company employs over 26,000 people, suggesting a significant operational scale.
- Long Operating History: The company was founded in 1835, indicating a long history in the industry.
CAKFY Preguntas Frecuentes sobre Acciones de Healthcare
¿Cuáles son los factores clave para evaluar CAKFY?
McKesson Europe AG (CAKFY) actualmente tiene una puntuación IA de 35/100, indicando puntuación baja. Fortaleza clave: Extensive distribution network across Europe.. Riesgo principal a monitorear: Ongoing: Increasing competition from other pharmaceutical distributors and retail pharmacy chains.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CAKFY?
CAKFY actualmente puntúa 35/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CAKFY?
Los precios de CAKFY se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CAKFY?
La cobertura de analistas para CAKFY incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CAKFY?
Las categorías de riesgo para CAKFY incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Increasing competition from other pharmaceutical distributors and retail pharmacy chains.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CAKFY?
La relación P/E para CAKFY compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CAKFY sobrevalorada o infravalorada?
Determinar si McKesson Europe AG (CAKFY) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CAKFY?
McKesson Europe AG (CAKFY) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on available sources and may be limited due to the company's OTC listing.
- Financial data is as of the latest available reporting period.